Effective Date: January 15, 2004 OPTION AGREEMENTOption Agreement • May 4th, 2007 • AspenBio Pharma, Inc. • In vitro & in vivo diagnostic substances • Colorado
This OPTION AGREEMENT (the “Agreement”) certifies that Strategic Growth International, Inc. (“Holder”), subject to the terms and conditions hereof, is entitled to purchase from AspenBio Pharma, Inc., f/k/a AspenBio, Inc., (the “Company”), 798,000 shares (the “Option Shares”) of Company common stock, no par value. This option, together with all options hereafter issued in exchange or substitution for this option, is referred to as the “Option.” The number of Option Shares is subject to adjustment as provided in Section 5 below. Notwithstanding anything to the contrary contained herein, this Option shall expire at 5:00 p.m. MST on January 15, 2009 (the “Termination Date”).
